CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant

Liver International

Volumn 33, Issue 1, 2013, Pages 72-78

  Firpi, Roberto J ^a   Dong, Huijia ^b   Clark, Virginia C ^a   Soldevila Pico, Consuelo ^a   Morelli, Giuseppe ^a   Cabrera, Roniel ^a   Norkina, Oxana ^a   Shuster, Jonathan J ^a   Nelson, David R ^a   Liu, Chen ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Fibrosis; Immunosuppression; Polymorphism; Survival; Sustained viral response

Indexed keywords

ALPHA2B INTERFERON; INTERLEUKIN 28B; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; DONOR; FEMALE; GENOTYPE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER GRAFT; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTIVIRAL AGENTS; BIOPSY; FEMALE; FLORIDA; GENOTYPE; HEPATITIS C; HUMANS; INTERLEUKINS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84870812020     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12013     Document Type: Article

References (14)

1. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996 Mar; 334: 815-20.
2. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009 Sep 17; 461: 399-401.
3. Balagopal A, Thomas DL, Thio CL. IL28B and the control of hepatitis C virus infection. Gastroenterology 2010 Dec; 139: 1865-1876.
4. Fukuhara T, Taketomi A, Motomura T, et al. Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. Gastroenterology 2010;139:1577-85.
5. Lange CM, Moradpour D, Doehring A, et al. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection. J Hepatol 2011; 55: 322-27.
6. Coto-Llerena M, Perez-Del-Pulgar S, Crespo G, et al. Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation. Am J Transplant 2011; 11: 1051-7.
7. Eurich D, Boas-Knoop S, Ruehl M, et al. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation. Liver Transpl 2011; 17: 289-98.
8. Charlton MR, Thompson A, Veldt BJ, et al. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology 2011; 53: 317-24.
9. Coto-Llerena M, Crespo G, Gonzalez P, et al. Determination of IL28B polymorphisms in liver biopsies obtained after liver transplantation. J Hepatol 2012; 56: 355-8.
10. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1991; 22: 696-9.
11. Tillmann HL, Thompson AJ, Patel K, et al. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 2010;139:1586-92.
12. Cyr DD, Lucas JE, Thompson JW, et al. Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C. PLoS ONE 2011; 6: e21854.
13. Duarte-Rojo A, Veldt BJ, Goldstein DD, et al. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables. Transplantation 2012; 94: 197-203.
14. Cisneros E, Banos I, Citores MJ, et al. Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T Allele of IL28B rs12979860. Transplantation 2012; 94: 275-80.